Powered 500 · 2026POWEREDS. 408 of 500
By acquiring undervalued drug candidates from big pharma and spinning each into a focused subsidiary, Ramaswamy built Roivant Sciences from a 2014 startup into a multi-billion-dollar biopharmaceutical family spanning dermatology, oncology, and neurology.
Vivek Ramaswamy is the Co-Founder and Executive Chairman of Strive Asset Management, the investment firm he co-founded to offer indexed funds focused on shareholder primacy.
He previously founded Roivant Sciences in 2014, building a biopharmaceutical company that creates focused subsidiary 'vant' companies to develop therapies, and has become a prominent figure in American public discourse. Ramaswamy is a Yale Law graduate.
Interview · In Pipeline
Sponsored placement
An invitation, extended to Powered readers.
Drive the Continental GT S.
Request a test driveBentley T&Cs apply
